GlassScriptPhysician profile
Andrew Banos
NPI 1154610384
$26,128.32
in general payments reported to CMS, 2019-2025
18 companies · $2,061 in 2025
The $2,061 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,096 · 2020: $311 · 2021: $4,219 · 2022: $3,840 · 2023: $378 · 2024: $7,224 · 2025: $2,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Food and Beverage: $3,145 · Travel and Lodging: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Food and Beverage | $3,145.49 |
| Travel and Lodging | $1,017.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $11,858.92 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Aequalis Perform |
| Vericel Corporation | $5,720.38 | 2019-2024 | Maci |
| Smith+Nephew, INC. | $3,634.83 | 2019-2024 | |
| Arthrex, INC. | $2,346.00 | 2019-2021 | |
| Kairos Surgical INC | $1,766.56 | 2019-2021 | |
| Fidia Pharma USA INC. | $245.10 | 2020-2025 | Hymovis, Triluron, Hyalgan |
| Zimmer Biomet Holdings, INC. | $147.60 | 2025 | G7 |
| Integra Lifesciences Corporation | $142.79 | 2020 | |
| Acumed LLC | $42.79 | 2022 | |
| Endo Pharmaceuticals INC. | $39.98 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $38.76 | 2025 | |
| Next Science LLC | $29.22 | 2023 | Xperience, Blastx, Surgx |
| Pacira Pharmaceuticals Incorporated | $25.98 | 2019 | |
| Abbott Laboratories | $24.62 | 2023 | Proclaim |
| Depuy Synthes Sales INC. | $17.38 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $17.21 | 2022 | |
| Pacira Therapeutics, INC. | $16.58 | 2019 | |
| Powerlink Ai, INC. | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Banos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.